In an earlier study, oral administration of BKM120 in several Her2+ multi-organ metastasis models led to a strong reduction in BCBM tumor burden [82], showing promise for further studies of PI3K inhibition in BCBMs. This evidence concerns the gene ERBB2 and neoplasm.